ReviewFrontiers in immunology2022
The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application.
Jin-Ling Huo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
111 papers cite itlatest 60 shown
this paperpooled ittrialcites it